Toxin A, Clostridium difficile (Actoxumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-Toxin A, Clostridium difficile (Actoxumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityToxin A, Clostridium difficile (Actoxumab biosimilar)
CloneActoxumab
Host SpeciesRecombinant
Reactive Speciesn/a
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsFuncS, IF, Neut, ELISA, FCM, IP, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Clostridium Difficile Toxin A Recombinant Antibody. Actoxumab is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infection. This drug, along with bezlotoxumab, was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School.
Immunogenn/a
Other NamesAnti-Toxin A Recombinant Antibody, Research Grade Actoxumab, Anti-Clostridium Difficile Toxin A Recombinant Antibody, CDA 1, MBL-CDA1, Antibody Drug Analogues, Monoclonal Antibody, YR1272, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1245634-25-6
Catalog #YR1272
Priceplease inquire
Order / More InfoToxin A, Clostridium difficile (Actoxumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.